Clinical Study of Memory Disorders in Aging Patients with Associated Cardiovascular, Neurological, Neurobehavioral and Metabolic Diseases”. A Review
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.contributor.author | Castejón, OJ. | |
| dc.contributor.author | Carrero-González, Carmen María | |
| dc.contributor.author | Martínez Royert, Judith Cristina | |
| dc.contributor.author | Galindez, P. | |
| dc.contributor.author | Salones de Castejón, M. | |
| dc.contributor.author | Sierra-Carrero, Leandro Luis | |
| dc.contributor.author | Prada Soto, Silvia Juliana | |
| dc.date.accessioned | 2021-03-23T20:33:58Z | |
| dc.date.available | 2021-03-23T20:33:58Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | We have observed semantic memory and episodic memory disorders (100%) in patients ranging from 40 to 92 years-old, associated to cardiovascular diseases and blood hypertension (82%), sleep disorders (50%), neurobehavioral disorders (44%), such as depression, anxiety, aggression, and vascular demencia, disorders of language (36%), neurosensory disorders (28%), as diminution of visual and hearing acuity, dizziness (26%), Parkinson disease (34%), Alzheimer disease (21%), gait disturbances (10%), vertigo (10%), cervicalgia and cervicogenic headache (10%) trigeminal neuralgia (2%,), We observed as comorbidities the following non-nervous diseases: metabolic diseases as diabetes (21%) and hypothyroidism (5%), gastrointestinal pathology (21%), such as constipation, loss of sphincter control, and gastritis, arthritis (13%), prostatic hypertrophy (1%) and loss of weight (1%). We consider that according to their high frequency the most risk factors associated to memory disorders are cardiovascular diseases and blood hypertension (82%), sleep disorders (50%), neurobehavioral disorders (44%), such as depression, anxiety, aggression, and vascular demencia, disorders of language (36%), neurosensory disorders (28%), as diminution of visual and hearing acuity, dizziness (26%), and Parkinson disease (34%). | eng |
| dc.format.mimetype | spa | |
| dc.identifier.citation | Castejón OJ, Carrero González CM, Judith Cristina Martínez Royert, Galindez P, Salones de Castejón M et, al (2021) “Clinical Study of Memory Disorders in Aging Patients with Associated Cardiovascular, Neurological, Neurobehavioral and Metabolic Diseases”. A Review. Journal of Clinical Case Studies Reviews & Reports. SRC/JCCSR-109. | eng |
| dc.identifier.issn | 2634680X | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/7189 | |
| dc.identifier.url | https://www.onlinescientificresearch.com/articles/ldquoclinical-study-of-memory-disorders-in-aging-patients-with-associated-cardiovascular-neurological-neurobehavioral-and-metaboli.pdf | eng |
| dc.language.iso | eng | eng |
| dc.publisher | Scientific Research and Community | eng |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Journal of Clinical Case Studies, Reviews & Reports. J Clin Stud Rev Rep, | eng |
| dc.source | Vol. 3 No. 2 (2021) | |
| dc.subject | Memory | eng |
| dc.subject | Aging patients | eng |
| dc.subject | Cardiovascular | eng |
| dc.subject | Neurological | eng |
| dc.subject | Neurobehavioral | eng |
| dc.subject | Metabolic diseases | eng |
| dc.title | Clinical Study of Memory Disorders in Aging Patients with Associated Cardiovascular, Neurological, Neurobehavioral and Metabolic Diseases”. A Review | eng |
| dc.type.driver | info:eu-repo/semantics/article | eng |
| dc.type.spa | Artículo científico | spa |
| dcterms.references | Román GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, et al. (2004) Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 226: 81-87. | eng |
| dcterms.references | Cicconetti P, Riolo N, Priami C, Tafaro L, Ettore E (2004) Risk factors for cognitive impairment. Recenti Prog Med 95: 535-545. | eng |
| dcterms.references | Erkinjuntti T (2007) Vascular cognitive deterioration and stroke. Cerebrovasc Dis 1: 189-194. | eng |
| dcterms.references | Chiu PY, Liu CH, Tsai CH (2007) Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia. Acta Neurol Taiwan 16: 86-91. | eng |
| dcterms.references | Jellinger KA (2008) Morphologic diagnosis of “vascular dementia” - a critical update. J Neurol Sci 270: 1-12. | eng |
| dcterms.references | Miley-Akerstedt A, Jelic V, Marklund K, Walles H, Åkerstedt T, et al. (2018) Lifestyle Factors Are Important Contributors to Subjective Memory Complaints among Patients without Objective Memory Impairment or Positive Neurochemical Biomarkers for Alzheimer’s disease. Dement Geriatr Cogn Dis Extra 8: 439-452. | eng |
| dcterms.references | Jawaid A, Woldemichael BT, Kremer EA, Laferriere F, Gaur N, et al. (2019) Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 Biogenesis. Mol Neurobiol 56: 3451-3462. | eng |
| dcterms.references | Toledo C, Andrade DC, Díaz HS, Inestrosa NC, Del Rio R (2019) Neurocognitive Disorders in Heart Failure: Novel Pathophysiological Mechanisms Underpinning Memory Loss and Learning Impairment. Mol Neurobiol 56: 8035-8051. | eng |
| dcterms.references | Castejón OJ, Carrero González CM, Lastre-Amell G, Leal J, Galindez P, et al. (2020) Clinical and neuroimaging study of thirty three patients with vascular dementia in neurological, psychiatric and cardiovascular diseases exhibiting microangiopathy and leukoencephalopathy”. EC Neurology 3: 01-13. | eng |
| dcterms.references | Nasrouei S, Rattel JA, Liedlgruber M, Marksteiner J, Wilhelm FH (2019) Fear acquisition and extinction deficits in amnestic mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging S0197-4580 30392-6. | eng |
| dcterms.references | Bayram E, Caldwell JZK, Banks SJ (2018) Current understanding of magnetic resonance imaging biomarkers and memory in Alzheimer’s disease. Alzheimers Dement (N Y) 4: 395-413. | eng |
| dcterms.references | Brueggen K, Kasper E, Dyrba M, Bruno D, Pomara N, Ewers M, et al. (2016) The Primacy Effect in Amnestic Mild Cognitive Impairment: Associations with Hippocampal Functional Connectivity. Front Aging Neurosci 8: 244. | eng |
| dcterms.references | Pan P, Zhu L, Yu T, Shi H, Zhang B, et al. (2019) Aberrant spontaneous low-frequency brain activity in amnestic mild cognitive impairment: A meta-analysis of resting-state fMRI studies. Ageing Res Rev 35:12-21. | eng |
| dcterms.references | Vipin A, Loke YM, Liu S, Hilal S, Shim HY, et al. (2018) Venketasubramanian N, Chen CL2, Zhou J. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer’s disease. Alzheimers Res Ther 10: 82. | eng |
| dcterms.references | Gottesman RF, Schneider AL, Albert M, Alonso A, Bandeen-Roche K, et al. (2014) Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol 71: 1218-1227. | eng |
| dcterms.references | Diekelmann S (2014) Sleep for cognitive enhancement. Front Syst Neurosci 8: 46. | eng |
| dcterms.references | Andersson C, Marklund K, Walles H, Hagman G, Miley-Akerstedt (2019) A Lifestyle Factors and Subjective Cognitive Impairment in Patients Seeking Help at a Memory Disorder Clinic: The Role of Negative Life Events. Dement Geriatr Cogn Disord 48: 196-206. | eng |
| dcterms.references | Gulia KK, Kumar VM (2018) Sleep disorders in the elderly: a growing challenge. Psychogeriatrics 18: 155-165. | eng |
| dcterms.references | Fortier-Brochu E, Morin CM (2014) Cognitive impairment in individuals with insomnia: clinical significance and correlates. Sleep 37: 1787-1798. | eng |
| dcterms.references | Brownlow JA, Miller KE, Gehrman PR (2020) Insomnia and cognitive performance. Sleep Med Clin 15: 71-76. | eng |
| dcterms.references | Momin RR, Ketvertis K.Primary Insomnia. StatPearls Publishing; 2020. | eng |
| dcterms.references | Grau-Rivera O., Operto G, Falcón C, Sánchez-Benavides G, Cacciaglia R, et al. (2020) Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults. Alzheimers Res Ther12:4. | eng |
| dcterms.references | Feld GB, Born J (2020) Neurochemical mechanisms for memory processing during sleep: basic findings in humans and neuropsychiatric implications. Neuropsychopharmacology 45: 31-44. | eng |
| dcterms.references | Sultzer DL, Leskin LP, Melrose RJ, Harwood DG, Narvaez TA, et al. (2014) Neurobiology of delusions, memory, and insight in Alzheimer disease. Am J Geriatr Psychiatry 22: 1346-1355. | eng |
| dcterms.references | Fossati P, Coyette F, Ergis AM, Allilaire JF (2002) Influence of age and executive functioning on verbal memory in patients with depression. J Affect Disord 68: 261-271. | eng |
| dcterms.references | Antonucci SM, Reilly J (2008) Semantic memory and language processing: a primer. Semin Speech Lang 29: 5-17. | eng |
| dcterms.references | Chertkow H, Whatmough C, Saumier D, Duong A (2008) Cognitive neuroscience studies of semantic memory in Alzheimer’s disease. Prog Brain Res 169: 393-407. | eng |
| dcterms.references | Laisney M, Giffard B, Eustache F (2004) Semantic memory in Alzheimer’s disease: contributions of semantic priming. Psychol Neuropsychiatr Vieil 2: 107-115. | eng |
| dcterms.references | Martnez-Sánchez F (2010) Speech and voice disorders in Parkinson’s disease. Rev Neurol 51: 542-550. | eng |
| dcterms.references | Ingvar DH (1983) Serial aspects of language and speech related to prefrontal cortical activity. A selective review. Hum Neurobiol 2:177-189. | eng |
| dcterms.references | Critchley EM (1981) Speech disorders of Parkinsonism: a review. J Neurol Neurosurg Psychiatry 44: 751-758. | eng |
| dcterms.references | Resende EPF, Nolan AL, Petersen C, Ehrenberg AJ, Spina S, et al. (2020) Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes: Astrocytic tau, cognitive function, and Alzheimer disease. Neurology.2020pii:10.1212/WNL.0000000000008937. | eng |
| dcterms.references | Hochstadt J, Nakano H, Lieberman P, Friedman J (2006) The roles of sequencing and verbal working memory in sentence comprehension deficits in Parkinson’s disease. Brain Lang 97: 243-257. | eng |
| dcterms.references | Dickson DW (2012) Parkinson’s disease and Parkinsonism: neuropathology. Cold Spring Harb Perspect Med 2). pii: a009258. | eng |
| dcterms.references | Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.Diabetologia 48: 2460-2469. | eng |
| dcterms.references | Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B, eta l. (2009) Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 73: 1359-1366. | eng |
| dcterms.references | Barbagallo M, Dominguez LJ (2014) Type 2 diabetes mellitus and Alzheimer’s disease. World J Diabetes 5: 889-893. | eng |
| dcterms.references | Perlmuter LC, Tun P, Sizer N, McGlinchey RE, Nathan DM (1987) Age and diabetes related changes in verbal fluency. Exp Aging Res. 1987 Spring-Summer; 13: 9-14. | eng |
| dcterms.references | Kirova AM, Bays RB, Lagalwar S (2015) Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer’s disease. Biomed Res Int 2015: 748212. | eng |
| dcterms.references | Rochoy M, Bordet R, Gautier S, Chazard E (2019) Factors associated with the onset of Alzheimer’s disease: Data mining in the French nationwide discharge summary database between 2008 and 2014. PLoS One 14: e0220174. | eng |
| dcterms.references | Skoog I, Gustafson D (2006) Update on hypertension and Alzheimer’s disease. Neurol Res 28: 605-611. | eng |
| dcterms.references | Paglieri C, Bisbocci D, Caserta M, Rabbia F, Bertello C, et al. (2008) Hypertension and cognitive function. Clin Exp Hypertens 30: 701-710. | eng |
| dcterms.references | Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, et al. (2010) Functional alterations in memory networks in early Alzheimer’s disease. Neuromolecular Med 12: 27-43. | eng |
| dcterms.references | Uchida Y, Sugiura S, Nishita Y, Saji N, Sone M, et al. (2019) Age-related hearing loss and cognitive decline - The potential mechanisms linking the two. uris Nasus Larynx 46: 1-9. | eng |
| dcterms.references | González-Arancibia C, Urrutia-Piñones J, Illanes-González J, Martinez-Pinto J, Sotomayor-Zárate R, et al. (2019) Do your gut microbes affect your brain dopamine?. Psychopharmacology (Berl) 236: 1611-1622. | eng |
| dcterms.references | Jones DJ, Harris JP, Vaux E, Hadid R, Kean R, et al. (2015) The nature of impairments of memory in patients with end-stage renal disease (ESRD). Physiol Behav 147: 324-333. | eng |
| dcterms.references | Huang L, Yang L, Wu P, Yan X, Luo L, et al. (2017) Low-grade albuminuria is associated with poor memory performance in the nondemented Chinese elderly with type 2 diabetes. Metab Brain Dis 32: 1975-1981. | eng |
| dcterms.references | Sacre JW, Magliano DJ, Zimmet PZ, Polkinghorne KR, Chadban SJ, et al. (2019) Anstey KJ, Shaw JE. Associations of Chronic Kidney Disease Markers with Cognitive Function: A 12-Year Follow-Up Study. J Alzheimers Dis 70: S19-S30. | eng |
| dcterms.references | Kuźma E, Soni M, Littlejohns TJ, Ranson JM, van Schoor NM, et al. (2016) Vitamin D and Memory Decline: Two Population-Based Prospective Studies. J Alzheimers Dis 50: 1099-1108. | eng |
| dcterms.references | Castro-Chavira SA, Aguilar-Vázquez AR, Martínez-Chávez Y, Palma L, Padilla-Gómez E, et al. (2016) Effects of chronic malnourishment and aging on the ultrastructure of pyramidal cells of the dorsal hippocampus. Nutr Neurosci 19: 329-336. | eng |
| dcterms.references | Moon Y, Moon WJ, Kwon H, Lee JM, Han SH (2015) Vitamin D deficiency disrupts neuronal integrity in cognitively impaired patients. J Alzheimers Dis 45: 1089-1096. | eng |
| dcterms.references | Fama R, Pitel AL, Sullivan EV (2012) Anterograde episodic memory in Korsakoff syndrome. Neuropsychol Rev 22: 93-104. | eng |
| dcterms.references | Bauer E, Toepper M, Gebhardt H, Gallhofer B, Sammer G (2020) The significance of caudate volume for age-related associative memory decline. Brain Res 1622: 137-148. | eng |
| dcterms.references | Bettcher BM, Mungas D, Patel N, Elofson J, Dutt S, et al. (2016) Neuroanatomical substrates of executive functions: Beyond prefrontal structures. Neuropsychologia 85:100-109. | eng |
| dcterms.references | Kennedy KM, Raz N (2000) Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 947: 916-927. | eng |
| dcterms.references | Gunning-Dixon FM, Brickman AM, Cheng JC, Alexopoulos GS (2009) Aging of cerebral white matter: a review of MRI findings. Int J Geriatr Psychiatry 24: 109-117. | eng |
| dcterms.references | Zheng F, Cui D, Zhang L, Zhang S, Zhao Y, et al. (2018) The volume of hippocampal subfields in relation to decline of memory recall across the adult lifespan. Front Aging Neurosci 10: 320. | eng |
| dcterms.references | Wang N, Zhang L, Yang H, Luo X, Fan G (2019) Do multiple system atrophy and Parkinson’s disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study. Eur Radiol 29: 4948-4956. | eng |
| dcterms.references | Jia X, Wang Z, Yang T, Li Y, Gao S, et al. (2019) Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s disease with Mild Cognitive Impairment. Aging Dis 10: 1221-1232. | eng |
| dcterms.references | Hu Y, Du W, Zhang Y, Li N, Han Y, et al. (2019) Loss of Parietal Memory Network Integrity in Alzheimer’s disease.] Front Aging Neurosci 11: 67. | eng |
| dcterms.references | Mayes AR (1986) Learning and memory disorders and their assessment. Neuropsychologia 24: 25-39. | eng |
| dcterms.references | Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases. Ann N Y Acad Sci 893: 154-175. | eng |
| dcterms.references | Patel R, Brophy C, Hickling M, Neve J, Furger A (2019) Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson’s, Alzheimer’s and ALS disease. BMC Med Genomics 12: 60. | eng |
| dcterms.references | Jellinger K (1987) Neuropathological substratesof Alzheimer’s disease and Parkinson’s disease 24: 109-129. | eng |
| dcterms.references | Franco R, Navarro G, Martínez-Pinilla E (2019) Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson’s and Alzheimer’s Diseases. Int J Mol Sci 20: E3297. | eng |
| dcterms.references | Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, et al. (1995) Damage to dopamine systems differs between Parkinson’s disease and Alzheimer’s disease with Parkinsonism. Ann Neurol 37: 300-312. | eng |
| dcterms.references | Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ (1997) Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson’s, Alzheimer’s with Parkinsonism, and Alzheimer’s disease. Mov Disord 12: 885-897. | eng |
| dcterms.references | Jorge LL, Gerard C, Revel M (2009) Evidences of memory dysfunction and maladaptive coping in chronic low back pain and Eur J Phys Rehabil Med 45: 469-477. | eng |
| dcterms.references | Lee JH, Kim GT, Kim YK, Lee SG (2018) Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes. Clin Exp Rheumatol 36: 856-861. | eng |
| dcterms.references | Appenzeller S, Bertolo MB, Costallat LT (2004) Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 26: 339-343. | eng |
| dcterms.references | Simos P, Ktistaki G, Dimitraki G, Papastefanakis E, Kougkas N, et al. (2016) Cognitive deficits early in the course of rheumatoid arthritis. J Clin Exp Neuropsychol 38: 820-829. | eng |
| dcterms.references | Hamed SA, Selim ZI, Elattar AM, Elserogy YM, Ahmed EA, et al. (2012) Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin Rheumatol 31: 123-132. | eng |
| dcterms.references | Jarzemski P, Brzoszczyk B, Popiołek A, Stachowicz-Karpińska A, Gołota S, et al. (2019) Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment. Neuropsychiatr Dis Treat 15: 819-829. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion | eng |